Open Beta
MetriLume

US marketsJAGX

SEC-sourced researchBeta

JAGX

Jaguar Health, Inc.

Company comparison ↗

Data passport

CIK
0001585608
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Oct 5, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 11,689,000.0000 USD; December 2025: 11,511,000.0000 USD11.7M USD0 USD0December 2024December 2025
JAGX · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202411,689,000.0000Apr 7, 2026
December 202511,511,000.0000Apr 7, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202511,511,000.0000-53,575,000.0000-23,686,000.000038,323,000.000057,011,000.0000Apr 7, 2026
December 202411,689,000.0000-38,492,000.0000-29,384,000.000053,425,000.000044,446,000.0000Apr 7, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$11.51MDecember 2025Apr 7, 202610-K
Previous period revenueRevenues$11.69MDecember 2024Apr 7, 202610-K
Net incomeNetIncomeLoss-$53.58MDecember 2025Apr 7, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$23.69MDecember 2025Apr 7, 202610-K
Total assetsAssets$38.32MDecember 2025Apr 7, 202610-K
Total liabilitiesLiabilities$57.01MDecember 2025Apr 7, 202610-K

New filings

Explore methodology ↗